Personalized immune cell therapy plus radiation for advanced cancer
Part of Cancer, Digestive system, Lungs & breathing, Skin clinical trials.
This study tests a personalized treatment that uses your own immune cells, trained to recognize your tumor, combined with radiation therapy. It is for people with advanced cancer that has not responded to standard treatments, and aims to help the body fight the cancer more effectively.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 80 years old.
- You have advanced or recurrent cancer that has worsened despite standard treatment, and no better treatment options are available.
- You have at least one tumor that can be measured on imaging scans.
- You are expected to live at least 6 more months and are in fairly good health (able to care for yourself).
- You are willing to have a sample of your tumor removed (by surgery or biopsy) to create the personalized treatment, and to give blood samples for research.
- You do not have certain infections (like HIV, hepatitis) or autoimmune diseases, and you are not on long-term steroids or other immune-suppressing drugs.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of radiation combined with immunotherapy for people with advanced solid tumors that are no longer responding to standard treatments or cannot tolerate them. The goal is to see if this combination can help control the disease.
This trial tests a treatment made from your own immune cells (called tumor-infiltrating lymphocytes). The cells are taken from a tumor sample, multiplied in a lab, and given back to you to help fight the cancer. It's for people with melanoma that has not responded to standard immunotherapy.
This trial tests a personalized treatment using your own immune cells (T cells) that are specially trained to find and attack lung cancer cells. It may help people with advanced or relapsed lung cancer who have not improved with standard treatments.
This trial tests a personalized cancer vaccine combined with a special type of radiation therapy for people with advanced or recurrent cancers that no longer respond to standard treatments. The goal is to help your immune system better recognize and attack your cancer.
This study tests a combination of a personalized vaccine made from your tumor's unique markers, a type of immunotherapy (PD-1 inhibitor), and radiation. The goal is to see if this mix can work better for advanced lung cancer that has progressed after initial treatment.
This trial tests a personalized vaccine made from your own cells to help your immune system attack tumor-specific targets. It may be an option if standard treatments have stopped working or caused side effects you can't tolerate.
Hear when a new Melanoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.